Best of Lung Cancer Conference 2026
Conference Venue: Vantage Venues
Venue Address: 150 King St W, Toronto, ON M5H 1J9
Directions: Google Maps Link
Event Landscape
Chaired by Dr. Rosalyn Juergens and Dr. Vishal Navani, the Best of Lung Cancer Conference 2026 offers Canadian oncology professionals a unique opportunity to stay current on the most impactful lung cancer data and treatment advances presented at ASCO® and ESMO 2026 congresses. Expert speakers will distill key trials and clinical findings into actionable insights, helping clinicians integrate new standards of care and diagnostic tools into their practice. This conference is essential for staying at the forefront of lung cancer treatment and enhancing patient outcomes with the most current, evidence-based practices.
Learning Objectives
- Evaluate uncommon thoracic malignancies relevant to lung cancer practice, including mesothelioma, large cell neuroendocrine carcinoma, and thymic epithelial tumors.
- Explore emerging innovations in lung cancer management, with a focus on robotic-assisted surgery, stereotactic body radiation therapy (SBRT), and the clinical application of antibody-drug conjugates (ADCs).
- Analyze recent advances and evolving standards of care in HER2-driven and other molecular subtypes of lung cancer, emphasizing personalized treatment approaches.
Scientific Agenda
Click below to learn more about the scheduled presentations and incredible speaker lineup
Event Co-Chairs
Dr. Rosalyn Juergens
B.S. (Hons), MD, PhD
Dr. Juergens completed a fellowship in medical oncology with a focus on thoracic
malignancies at the Johns Hopkins Medical Institute. Additionally, she completed her Ph.D. in Clinical Investigation at The Johns Hopkins Bloomberg School of Public Health. She was on the faculty at Johns Hopkins from 2007-2010 until she joined the faculty at McMaster University in 2011.
Dr. Juergens’ clinical expertise is in lung cancer. Her research focus has been in
developmental therapeutics with a concentration on Phase I and II clinical trials. Her passion is expanding knowledge and access to clinical trials. She is a member of the Early Therapy Advisory Committee and member of the Lung Disease Site Group Executive in the Canadian Cancer Trials Group.
She chaired the Lung Cancer Disease Site Team at the Juravinski Cancer Centre from 2013-2024. She is the Head of the Department of Clinical Trials at the Juravinski Cancer Centre.
She is a member of the Escarpment Cancer Research Institute and the Centre for Discovery and Cancer Research at McMaster University.
She is a proud teacher and mentor and winner of the 2024 Women in Cancer Mentor of the Year. She is also a patient advocate. She is the current President of Lung Cancer Canada. Her efforts were acknowledged by the 2024 Canadian Association of Medical Oncologists Humanitarian Award.
Dr. Vishal Navani
MA (Oxon), MBBS, MRCP, FRACP
Dr. Vishal Navani is a staff medical oncologist at the Tom Baker Cancer Centre and an Assistant Professor (Clinical) at the University of Calgary. He previously graduated from Oxford and Imperial College London. He holds both Membership of the Royal College of Physicians of the United Kingdom and Fellowship of the Royal Australasian College of Physicians.
His academic focus includes the interrogation of large real world datasets spanning tumour streams in order to generate practical insights that can be used in the clinic. He treats patients with thoracic and GU malignancies. He is the principal director of Glans Look Research, one of North America’s largest lung cancer databases. He leads the Thoracic Oncology residency training programme at the University of Calgary and mentors dozens of undergraduate and post-graduate learners.
His work includes over 60 manuscripts and abstracts and has been published extensively in high impact journals, including JAMA Oncology, European Urology and an upcoming editorial in the Lancet Oncology. He is a peer reviewer for the JCO and on the editorial board of Therapeutic Advances in Medical Oncology. He has won competitive Canadian grant funding and international awards including ASCO Merit awards. He plays a lead role in academic endeavours at the University of Calgary such as the Precision Oncology and Experimental Therapeutics initiative and has contributed as a clinical expert to CADTH national drug reimbursement decisions.
Sponsorship
For sponsorship-related inquiries, please contact your Director of Strategic Partnerships or visit our website at https://www.oncologyeducation.com/about-us/improving-patient-care-through-oncology-education/.
Conference Sponsors
Silver sponsor
Bronze sponsor
Please note mdBriefCase Group Inc. O/A Oncology Education cannot provide visa support for event attendees, including letters of invitation. Event attendees are solely responsible for obtaining any necessary documentation required for travel and participation in the event. No refunds shall be provided to individuals who are unable to attend.